Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration

Neurological Sciences

Volumn 33, Issue 6, 2012, Pages 1393-1396

  Kim, Heyun ^a   Chu, Kon ^b   Jung, Keun Hwa ^b   Lee, Soon Tae ^b   Kim, Jeong Min ^b   Lee, Sang Kun ^b  

^a Catholic Kwandong University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Carnitine deficiency; Diffusion magnetic resonance imaging; Encephalopathy

Indexed keywords

CARNITINE; CEFDITOREN PIVOXIL; VALPROIC ACID; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BASAL GANGLION; BLOOD GAS ANALYSIS; BLURRED VISION; BRAIN HEMORRHAGE; CARNITINE DEFICIENCY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONSCIOUSNESS; CYTOTOXICITY; DISEASE ASSOCIATION; EDEMA; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYSTERECTOMY; INFECTION CONTROL; MENTAL DISEASE; METABOLIC ACIDOSIS; METABOLIC ENCEPHALOPATHY; MIDDLE AGED; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; POSTOPERATIVE INFECTION; RETINA IMAGE; SUPPLEMENTATION; TONIC CLONIC SEIZURE; WHITE MATTER; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; HYPERAMMONEMIA; MUSCLE DISEASE;

ANTI-BACTERIAL AGENTS; BRAIN DISEASES, METABOLIC; CARDIOMYOPATHIES; CARNITINE; CEPHALOSPORINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERAMMONEMIA; MIDDLE AGED; MUSCULAR DISEASES;

EID: 84883639295     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-0939-7     Document Type: Article

References (11)

1. Holme E, Greter J, Jacobson CE, Lindstedt S, Nordin I, Kristiansson B, Jodal U (1989) Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2(8661):469-473
2. Reuter SE, Evans AM, Chace DH, Fornasini G (2008) Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann ClinBiochem. 45(Pt 6):585-592
3. Virmani A, Binienda Z (2004) Role of carnitine esters in brain neuropathology. Mol Aspects Med 25(5-6):533-549
4. Schäfer J, Reichmann H (1990) Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study. J Neurol 237(3):213-215
5. Winter SC, Szabo-Aczel S, Curry CJ, Hutchinson HT, Hogue R, Shug A (1987) Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child 141(6):660-665
6. Ito T, Sugiyama N, Kobayashi M et al (1995) Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid containing prodrugs. Tohoku J Exp Med 175:43-53
7. Lheureux PE, Penaloza A, Zahir S, Gris M (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity- what is the evidence? Crit Care 9(5):431-440
8. Averbuch-Heller L, Ben-Hur T, Reches A (1994) Valproate encephalopathy and hypocarnitinaemia in diabetic patients. J Neurol 241:567-569
9. Stanley CA (2004) Carnitine deficiency disorders in children. Ann N Y Acad Sci 1033:42-51
10. Todesco L, Bodmer M, Vonwil K, Häussinger D, Krähenbühl S (2009) Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells over expressing hOCTN2. ChemBiol Interact 180(3):472-477
11. Bianchi MC, Sgandurra G, Tosetti M, Battini R, Cioni G (2007) Brain magnetic resonance in the diagnostic evaluation of mitochondrial. EncephalopathiesBiosci Rep 27:69-85